Cited by 887PI3K/AKT/mTOR signaling in cancerSignaling Pathways in DiseaseAutophagy in Disease and Therapy

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

Open access

Sabers, Candace J., Martin, Mary M., Brunn, Gregory J., Williams, Josie M., Dumont, Francis J., Wiederrecht, Gregory, Abraham, Robert T.·1995·Journal of Biological Chemistry

DOI 10.1074/jbc.270.2.815

Open this paper in CoChat — free account Open PDF

Abstract

The immunosuppressive drug, rapamycin, interferes with an undefined signaling pathway required for the progression of G1-phase T-cells into S phase. Genetic analyses in yeast indicate that binding of rapamycin to its intracellular receptor, FKBP12, generates a toxic complex that inhibits cell growth in G1 phase. These analyses implicated two related proteins, TOR1 and TOR2, as targets of the FKBP12-rapamycin complex in yeast. In this study, we have used a glutathione S-transferase (GST)-FKBP12-rapamycin affinity matrix to isolate putative mammalian targets of rapamycin (mTOR) from tissue extracts. In the presence of rapamycin, immobilized GST-FKBP12 specifically precipitates similar high molecular mass proteins from both rat brain and murine T-lymphoma cell extracts. Binding experiments performed with rapamycin-sensitive and -resistant mutant clones derived from the YAC-1 T-lymphoma cell line demonstrate that the GST-FKBP12-rapamycin complex recovers significantly lower amounts of the candidate mTOR from rapamycin-resistant cell lines. The latter results suggest that mTOR is a relevant target of rapamycin in these cells. Finally, we report the isolation of a full-length mTOR cDNA that encodes a direct ligand for the FKBP12-rapamycin complex. The deduced amino acid sequence of mTOR displays 42 and 45% identity to those of yeast TOR1 and TOR2, respectively. These results strongly suggest that the FKBP12-rapamycin complex interacts with homologous ligands in yeast and mammalian cells and that the loss of mTOR function is directly related to the inhibitory effect of rapamycin on G1- to S-phase progression in T-lymphocytes and other sensitive cell types.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.270.2.815

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P. E., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,090
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,010
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
Clipstone, N. A., & Crabtree, G. R. (1992) · Nature · doi:10.1038/357695a0 · Cited by 1,635
RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239
Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases
Chung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,151

Flagged first, then by citations

Show all 29 references

Research works printed but not linked: 1

Cafferkey, 1993, Mol. Cell. Biol., 13, 6012, 10.1128/MCB.13.10.6012 · DOI

Sorted by citations

Items 601–700 of 885

Simultaneous activation of Kras–Akt and Notch pathways induces extrahepatic biliary cancer via the mTORC1 pathway
Namikawa, M., Fukuda, A., Mizukoshi, K., Iwane, K., Kawai, M., Yamakawa, G., Omatsu, M., Sono, M., Masuda, T., Araki, O., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6139 · Cited by 13
Inhibiteurs de mTOR : Des antiprolifératifs pléiotropiques
Pallet, N., Beaune, P. H., Thervet, É., Legendre, C. M., & Anglicheau, D. (2006) · médecine/sciences · doi:10.1051/medsci/20062211947 · Cited by 13
Peripheral Synthesis of an Atypical Protein Kinase C Mediates the Enhancement of Excitability and the Development of Mechanical Hyperalgesia Produced by Nerve Growth Factor
Kays, J. S., Zhang, Y. H., Khorodova, A., Strichartz, G. R., & Nicol, G. D. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.12.030 · Cited by 13
Autophagy as a pharmacological target in hematopoiesis and hematological disorders
Orsini, M., Morceau, F., Dicato, M. A., & Diederich, M. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.04.007 · Cited by 14
Cleavage of the cyclohexyl-subunit of rapamycin results in loss of immunosuppressive activity
Sedrani, R. C., Jones, L. H., Jutzi-Eme, A.-M., Schüler, W., & Cottens, S. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00007-4 · Cited by 13
X-ray Crystal Structure of 28-O-Methylrapamycin complexed with FKBP12: Is the Cyclohexyl Moiety Part of the Effector Domain of Rapamycin?
Kallen, J. A., Sedrani, R. C., & Cottens, S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja954328h · Cited by 13
Opposing effects of rapamycin and cyclosporin A on activation-induced Ca2+ release
Almawi, W. Y., Assi, J. W., Chudzik, D. M., & Lazarovits, A. I. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00558-0 · Cited by 13
Requirement of PI3-kinase activity for the nuclear transport of prolactin in cloned murine T lymphocytes
Belkowski, S. M., Levine, J. E., & Prystowsky, M. B. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00202-1 · Cited by 13
Signal integration in the (m)TORC1 growth pathway
Ramlaul, K., & Aylett, C. H. S. (2018) · Frontiers in Biology · doi:10.1007/s11515-018-1501-7 · Cited by 12
mTOR pathway inhibition in renal cell carcinoma
Marín, Á. P., Redondo, A., Arranz, E. E., Auñón, P., Fernández, B. C., & Barón, M. G. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.11.008 · Cited by 12
Small molecule H89 renders the phosphorylation of S6K1 and AKT resistant to mTOR inhibitors
Melick, C. H., & Jewell, J. L. (2020) · Biochemical Journal · doi:10.1042/bcj20190958 · Cited by 13
Chemical genetics: Reshaping biology through chemistry
Florian, S., Hümmer, S., Catarinella, M., & Mayer, T. U. (2007) · HFSP journal · doi:10.2976/1.2752600 · Cited by 12
Mammalian Target of Rapamycin as a Target in Hematological Malignancies
Abdel-Karim, I. A., & Giles, F. J. (2008) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2008.05.001 · Cited by 12
Unraveling the role of autophagy regulation in Crohn's disease: from genetic mechanisms to potential therapeutics
Yuan, Z., Ye, J., Liu, B., & Zhang, L. (2024) · Advanced Biotechnology · doi:10.1007/s44307-024-00021-z · Cited by 14
Novel Targets for Hypertension Drug Discovery
Bhatt, L. K., Selokar, I., Raut, D., & Hussain, T. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01137-6 · Cited by 11
G-Protein Coupled Receptor Signaling and Mammalian Target of Rapamycin Complex 1 Regulation
Melick, C. H., Lama-Sherpa, T. D., Curukovic, A., & Jewell, J. L. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000302 · Cited by 11
Deficiency in the Treatment Description of mTOR Inhibitor Resistance in Medulloblastoma, a Systematic Review
Alammar, H., Nassani, R., Alshehri, M. M., Aljohani, A. A., & Alrfaei, B. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010464 · Cited by 11
mTOR signaling in renal ion transport
Adella, A., & de Baaij, J. H. F. (2023) · Acta Physiologica · doi:10.1111/apha.13960 · Cited by 11
A Tripartite Complex HIV-1 Tat-Cyclophilin A-Capsid Protein Enables Tat Encapsidation That Is Required for HIV-1 Infectivity
Schatz, M., Marty, L., Ounadjela, C., Tong, P. B. V., Cardace, I., Mettling, C., Milhiet, P., Costa, L., Godefroy, C., Pugnière, M., et al. (2023) · Journal of Virology · doi:10.1128/jvi.00278-23 · Cited by 13
Temsirolimus
Stock, C., Zaccagnini, M., Schulze, M., Teber, D., & Rassweiler, J. J. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-01222-8_13 · Cited by 11
Crosstalk between the mTOR pathway and primary cilia in human diseases
Prosseda, P. P., Prosseda, S. D., Tran, M., Liton, P. B., & Sun, Y. (2023) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2023.09.004 · Cited by 11
Unraveling the therapeutic landscape of approved non-peptide macrocycles
Li, Z., Zhang, Z., & Yu, B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.04.021 · Cited by 10
Cell Type‐Specific mTORC1 Signaling and Translational Control in Synaptic Plasticity and Memory
Huang, Z., Mahmood, N., Wiebe, S. A., Khoutorsky, A., Lacaille, J., & Sonenberg, N. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70281 · Cited by 10
Metabolic Regulation of T Cell Immunity
Vignali, P., Barbi, J. J., & Pan, F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1170-6_2 · Cited by 10
Polycystin‐1 regulates cell proliferation and migration through AKT/mTORC2 pathway in a human craniosynostosis cell model
Katsianou, M. A., Papavassiliou, K. A., Gargalionis, A. N., Agrogiannis, G. D., Korkolopoulou, P. A., Panagopoulos, D., Themistocleous, M. S., Piperi, C., Basdra, E. K., & Papavassiliou, A. G. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17266 · Cited by 10
Ivermectin represses Wnt/β-catenin signaling by binding to TELO2, a regulator of phosphatidylinositol 3-kinase-related kinases
Yonezawa, H., Ikeda, A., Takahashi, R., Endo, H., Sugawara, Y., Goto, M., Kanno, M., Ogawa, S., Nakamura, K., Ujiie, H., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103912 · Cited by 10
Molecular biology and genetic models of glioma and medulloblastoma
Lassman, A. B., & Holland, E. C. (2006) · CRC Press eBooks · doi:10.1201/b13439-70 · Cited by 10
Influence of Age on Skeletal Muscle Hypertrophy and Atrophy Signaling: Established Paradigms and Unexpected Links
Lee, E. H., & Neppl, R. L. (2021) · Genes · doi:10.3390/genes12050688 · Cited by 11
Rapamycin inhibits hepatitis B virus covalently closed circular DNA transcription by enhancing the ubiquitination of HBx
Zhang, Y., Li, L., Cheng, S., Qin, Y.-P., He, X., Li, F., Wu, D., Ren, F., Yu, H., Liu, J., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.850087 · Cited by 10
Chemistry and Pharmacology of Rapamycin and Its Derivatives
Abraham, R. T., Gibbons, J. J., & Graziani, E. I. (2010) · The Enzymes · doi:10.1016/s1874-6047(10)27017-8 · Cited by 10
Self-citation
Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-Flurbiprofen regulates prostate stem cell antigen through activation of AKT kinase
Zemskova, M., Wechter, W. J., Bashkirova, S., Chen, C.-S., Reiter, R. E., & Lilly, M. B. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.028 · Cited by 10
How does the mammalian target of rapamycin (mTOR) influence CD8 T-cell differentiation?
Salmond, R. J., & Zamoyska, R. (2010) · Cell Cycle · doi:10.4161/cc.9.15.12358 · Cited by 10
Performance characteristics of a no-pretreatment, random access sirolimus assay for the Dimension® RxL clinical chemistry system
Cervinski, M. A., Duh, S., Hock, K. G., Gray, J., Wei, T. Q., Kilgore, D. C., Christenson, R. H., & Scott, M. G. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.03.009 · Cited by 10
New Frontiers in the Treatment of Multiple Myeloma
Hwang, J. J., Ghobrial, I. M., & Anderson, K. C. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.236 · Cited by 10
Practical applications of hydrostatic pressure to refold proteins from inclusion bodies for NMR structural studies
Ogura, K., Kobashigawa, Y., Saio, T., Kumeta, H., Torikai, S., & Inagaki, F. (2013) · Protein Engineering Design and Selection · doi:10.1093/protein/gzt012 · Cited by 10
Isolation of the mTOR Complexes by Affinity Purification
Sarbassov, D. D., Bulgakova, O., Bersimbaev, R. I., & Shaiken, T. E. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-430-8_5 · Cited by 10
An Inositolphosphate-Binding Immunophilin, IPBP12
Cunningham, E. B. (1999) · Blood · doi:10.1182/blood.v94.8.2778.420k10_2778_2789 · Cited by 10
Treating metastatic soft-tissue or bone sarcomas – potential role of ridaforolimus
Keedy, V. L. (2012) · OncoTargets and Therapy · doi:10.2147/ott.s19055 · Cited by 9
Exploring the anti-aging potential of natural products and plant extracts in budding yeast Saccharomyces cerevisiae: A review
Alugoju, P., Palanisamy, C. P., Anthikapalli, N. V. A., Jayaraman, S., Prasansuklab, A., Chuchawankul, S., Dyavaiah, M., & Tencomnao, T. (2023) · F1000Research · doi:10.12688/f1000research.141669.1 · Cited by 9
Bevacizumab and Rapamycin Can Decrease Corneal Opacity and Apoptotic Keratocyte Number following Photorefractive Keratectomy
Lee, K. S., Ko, D., Kim, E., Kim, M. J., Tchah, H., & Kim, J. Y. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10494 · Cited by 9
Immunosuppressive Activity of the Immunophilin‐binding Drug Sanglifehrin A in Human Whole Blood: Potent Inhibition of Interleukin‐6 Produced by Lymphocytes and Monocytes
Härtel, C., Iblher, P., Puzik, A., Wortmeier, K., Ebel, B., Schultz, C., & Müller‐Steinhardt, M. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01702.x · Cited by 9
Current state of mTOR targeting in human breast cancer.
Wazir, U., Wazir, A., Khanzada, Z. S., Jiang, W. G., Sharma, A. K., & Mokbel, K. (2014) · PubMed · Cited by 9
Evolution of TOR and Translation Control
Fonseca, B. D., Graber, T. E., Hoang, H., González, A., Soukas, A. A., Hernández, G., Alain, T., Swift, S. L., Weisman, R., Meyer, C., et al. (2016) · Springer eBooks · doi:10.1007/978-3-319-39468-8_15 · Cited by 9
S6K2 Promises an Important Therapeutic Potential for Cancer
Sever, N. İ., & Cengiz, S. (2018) · Future Oncology · doi:10.2217/fon-2018-0332 · Cited by 9
Crosstalk between the mTOR and DNA Damage Response Pathways in Fission Yeast
Alao, J. P., Legon, L., & Rallis, C. (2021) · Cells · doi:10.3390/cells10020305 · Cited by 9
Redundant electrostatic interactions between GATOR1 and the Rag GTPase heterodimer drive efficient amino acid sensing in human cells
Doxsey, D. D., Tettoni, S. D., Egri, S. B., & Shen, K. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104880 · Cited by 11
Overexpression or Downregulation of mTOR in Mammalian Cells
Khalil, M. I. M., & Gout, I. T. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-430-8_7 · Cited by 9
Tuberous sclerosis complex: genetic basis and management strategies
Crino, P. B., & Tsai (2012) · Advances in Genomics and Genetics · doi:10.2147/agg.s19837 · Cited by 9
H2O2 induces PP2A demethylation to downregulate mTORC1 signaling in HEK293 cells
Tang, S., Fu, Q., Wang, X., Liang, Z., Cai, H., Mo, L., Huang, Y., Liang, B., Wei, X., Ao, Q., et al. (2018) · Cell Biology International · doi:10.1002/cbin.10987 · Cited by 9
The three fates of immuno suppression in the next millenium: selectivity, synergy, and specificity
Kahan, B. D. (1996) · Transplant International · doi:10.1007/bf00335550 · Cited by 9
Regulation of cellular anabolism by mTOR: or how I learned to stop worrying and love translation
Deaver, J. W., López, S. M., Ryan, P. J., Nghiem, P. P., Riechman, S. E., & Fluckey, J. D. (2020) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2020.11.003 · Cited by 8
Aldosterone Modulates the Mechanistic Target of Rapamycin Signaling in Male Mice
Brooks, D. L. P., Garza, A., Katayama, I. A., Romero, J. R., Adler, G. K., Pojoga, L. H., & Williams, G. H. (2019) · Endocrinology · doi:10.1210/en.2018-00989 · Cited by 8
Preoperative Oral Carbohydrate Improved Postoperative Insulin Resistance in Rats through the PI3K/AKT/mTOR Pathway
Qin, H. (2014) · Medical Science Monitor · doi:10.12659/msm.891063 · Cited by 8
Rapamycin prevents Concanavalin A‐induced liver injury by inhibiting lymphocyte activation
Zhang, Y., Xiao, X., Li, X., & Wei, H. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05866.x · Cited by 8
Cellular Responses to DNA Damage and Human Chromosome Instability Syndromes
Khanna, K. K., Gatti, R. A., CONCANNON, P. J., Weemaes, C. M. R., Hoekstra, M. F., Lavin, M. F., & D’Andrea, A. D. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-455-9_19 · Cited by 8
Potential of Vitamin D and l -Cysteine Co-supplementation to Downregulate Mammalian Target of Rapamycin: A Novel Therapeutic Approach to Diabetes
Stevens, C. Μ., Weeks, K. R., & Jain, S. K. (2024) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2024.0146 · Cited by 12
Mitochondrial dysfunction as the “mother” of all hallmarks of aging
Weissig, V. (2025) · Journal of Mitochondria Plastids and Endosymbiosis · doi:10.1080/28347056.2025.2560191 · Cited by 9
Mammalian Target of Rapamycin as the Therapeutic Target of Vascular Proliferative Diseases: Past, Present, and Future
Huang, W.-Q., Zou, Y., Tian, Y., Ma, X.-F., Zhou, Q.-Y., Li, Z.-Y., Gong, S.-X., & Wang, A.-P. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001208 · Cited by 7
Analysis of Structure–Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei
Scheuplein, N. J., Bzdyl, N. M., Lohr, T., Kibble, E. A., Hasenkopf, A., Herbst, C., Sarkar‐Tyson, M., & Holzgrabe, U. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00458 · Cited by 7
Immunophyllin Ligands Show Differential Effects on Alcohol Self-Administration in C57BL Mice
Beresford, T. P., Fay, T., Serkova, N. J., & Wu, P. H. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188169 · Cited by 7
The PIKK Family of Protein Kinases
Smith, G. C. M., & Jackson, S. P. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50454-x · Cited by 7
Investigation of the effects of rapamycin on the mTOR pathway and apoptosis in metastatic and non-metastatic human breast cancer cell lines
Ekizceli, G., Uluer, E. T., & Inan, S. V. (2020) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2020_049 · Cited by 8
Tetrahydrohyperforin prevents articular cartilage degeneration and affects autophagy in rats with osteoarthritis
Zhang, J., Wang, S., Rong, G., Cheng, F., Gui, B., & Shen, C. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6098 · Cited by 7
TRANSLATIONAL CONTROL IN T LYMPHOCYTES
Beretta, L. (2004) · International Reviews of Immunology · doi:10.1080/08830180490452549 · Cited by 7
Platelet-Independent defect in hemostasis associated with sirolimus use
Rampino, T., Marasà, M., Malvezzi, P., Soccio, G., Roscini, E., Gamba, G., Noris, P., ALESSIANI, M., & Canton, A. D. (2004) · Transplantation Proceedings · doi:10.1016/j.transproceed.2004.03.015 · Cited by 7
X-ray Crystal Structure of 28-O-Methylrapamycin complexed with FKBP12: Is the Cyclohexyl Moiety Part of the Effector Domain of Rapamycin?
Kallen, J. A. (2012) · Worldwide Protein Data Bank · doi:10.2210/pdb4dh0/pdb · Cited by 7
Complex regulation of fatty liver disease
Ginsberg, H. N., & Mani, A. (2022) · Science · doi:10.1126/science.abp8276 · Cited by 7
Molecular Glue Degraders: From Serendipity to Hunting and Design
Nieto‐Barrado, L., Domostegui, A., & Mayor‐Ruiz, C. (2022) · Wiley eBooks · doi:10.1002/9783527836208.ch6 · Cited by 7
New Concepts in the Manipulation of the Aging Process
Hollands, P., & Ovokaitys, T. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230208102635 · Cited by 6
Disruption of lysosomal nutrient sensing scaffold contributes to pathogenesis of a fatal neurodegenerative lysosomal storage disease
Bagh, M. B., Appu, A. P., Sadhukhan, T., Mondal, A., Plavelil, N., Raghavankutty, M., Supran, A. M., Sadhukhan, S., Liu, A., & Mukherjee, A. B. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105641 · Cited by 7
Inhibitors identify an auxiliary role for mTOR signalling in necroptosis execution downstream of MLKL activation
Garnish, S. E., Horne, C. R., Meng, Y., Young, S. N., Jacobsen, A. V., Hildebrand, J. M., & Murphy, J. M. (2024) · Biochemical Journal · doi:10.1042/bcj20240255 · Cited by 7
The dual role of the TSC complex in cancer
Hartung, J., Müller, C., & Calkhoven, C. F. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.10.009 · Cited by 8
Protective Effect of Curcumin on Bone Trauma in a Rat Model via Expansion of Myeloid Derived Suppressor Cells
Zhang, F., Fu, L., Yu, S., Zhang, G., Li, J., & Sun, X. (2020) · Medical Science Monitor · doi:10.12659/msm.924724 · Cited by 6
Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1–KMT2A Interaction
Wolffhardt, T. M., Ketzer, F., Telese, S., Wirth, T., & Ushmorov, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216472 · Cited by 6
The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer
Konopa, K., & Jassem, J. (2009) · Current Drug Targets · doi:10.2174/138945010790030965 · Cited by 6
Genetically encoded tags for real time dissection of protein assembly in living cells
Ma, G., Zhang, Q., He, L., Nguyen, N. T., Liu, S., Gong, Z., Huang, Y., & Zhou, Y. (2018) · Chemical Science · doi:10.1039/c8sc00839f · Cited by 6
mTORC1 Deficiency Modifies Volume Homeostatic Responses to Dietary Sodium in a Sex-Specific Manner
Brooks, D. L. P., Garza, A., Guzelce, E. C., Gholami, K., Treesaranuwattana, T., Maris, S. A., Ranjit, S., Tay, C. S., Lee, J. M., Romero, J. R., et al. (2020) · Endocrinology · doi:10.1210/endocr/bqaa041 · Cited by 6
CF-PPiD technology based on cell-free protein array and proximity biotinylation enzyme for in vitro direct interactome analysis
Sugiyama, S., Yamada, K., Denda, M., Yamanaka, S., Ozawa, S., Morishita, R., & Sawasaki, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-14872-w · Cited by 6
David and Goliath: chemical perturbation of eukaryotes by bacteria
Ho, L., & Nodwell, J. R. (2015) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-015-1686-6 · Cited by 6
The PIKK Family of Protein Kinases
Smith, G. C. M., & Jackson, S. P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00077-2 · Cited by 7
Differential Role of Rapamycin and Torin/KU63794 in Inflammatory Response of 264.7 RAW Macrophages Stimulated by CA-MRSA
Shappley, R. K. H., & Spentzas, T. (2014) · International Journal of Inflammation · doi:10.1155/2014/560790 · Cited by 6
Potential of mTOR inhibitors as therapeutic agents in hematological malignancies
Sankhala, K. K., & Giles, F. J. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.31 · Cited by 6
Progress in artificial control system for gene expression
Zhang, Y., Zhao, N., & Liu, Q. (2000) · Chinese Science Bulletin · doi:10.1007/bf02886189 · Cited by 6
FK506: An Immunosuppressive Agent Preserving HIF-1 Activity
Kim, K., Jung, Y.-J., Yeo, E.-J., Chun, Y., & Park, J. (2006) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970601067094 · Cited by 6
Tuberous Sclerosis Complex
DiMario, F. J. (2019) · Wiley eBooks · doi:10.1002/9781119142812.ch143 · Cited by 6
A long and winding sTORy
(2017) · Nature Cell Biology · doi:10.1038/ncb3624 · Cited by 6
Targeting lysosomal pH restores mitochondrial quality control in GBA1-mutant Parkinson’s disease
Sheshadri, P., Costa-Besada, M. A., Fisher, A., Kiraly, S., Singh, K., Kourouzidou, I., Blacker, T. S., Zeng, J., Shirihai, O. S., Grinstaff, M. W., et al. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00559-z · Cited by 5
Differential protein expression in endothelial cells exposed to serum from patients with acute graft‐vs‐host disease, depending on steroid response
Martínez-Sánchez, J., Palomo, M., Pedraza, A., Moreno‐Castaño, A. B., Torramadé‐Moix, S., Rovira, M., Salas, M. Q., Cid, J., Escolar, G., Penack, O., et al. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17712 · Cited by 5
Exercise, mTOR Activation, and Potential Impacts on the Liver in Rodents
Onaka, G. M., de Carvalho, M. R., Onaka, P. K., Barbosa, C. M., Martinez, P. F., & de Oliveira-Junior, S. A. (2024) · Biology · doi:10.3390/biology13060362 · Cited by 6
TSC-mTORC1 Pathway in Postnatal V-SVZ Neurodevelopment
Feliciano, D. M., & Bordey, A. (2025) · Biomolecules · doi:10.3390/biom15040573 · Cited by 5
A Method to Rapidly Induce Organelle-Specific Molecular Activities and Membrane Tethering
Komatsu, T., & Inoue, T. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0944-5_16 · Cited by 5
Look who’s TORking: mTOR-mediated integration of cell status and external signals during limb development and endochondral bone growth
H’ng, C. H., Khaladkar, A., & Roselló‐Díez, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1153473 · Cited by 5
Rapamycin treatment induces tubular proteinuria: role of megalin-mediated protein reabsorption
Peres, R. A. S., Peruchetti, D. B., Silva-Aguiar, R. P., Teixeira¹, D. E., Gomes, C. P., Takiya, C. M., Pinheiro, A. A. S., & Caruso‐Neves, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1194816 · Cited by 5
Signalling pathway crosstalk stimulated by L-proline drives mouse embryonic stem cells to primitive-ectoderm-like cells
Glover, H. J., Holliday, H., Shparberg, R. A., Winkler, D. A., Day, M. L., & Morris, M. B. (2023) · Development · doi:10.1242/dev.201704 · Cited by 5
Novel therapies for patients with chronic myeloid leukemia
Giles, F. J., Kantarjian, H. M., & Cortes, J. E. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.2.271 · Cited by 5
S6 Kinase: A Compelling Prospect for Therapeutic Interventions
Majeed, S. T., Majeed, R., Shah, G., & Andrabi, K. I. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.75209 · Cited by 5
Regulation of TOR Signaling in Mammals
Lamming, D. W., & Sabatini, D. M. (2010) · The Enzymes · doi:10.1016/s1874-6047(10)27002-6 · Cited by 5
Synthesis and bioactivity of photolabile sirolimus (rapamycin) analogs
Chen, Y., Nakanishi, K., Merrill, D., Eng, C. P., Molnar-Kimber, K. L., Failli, A. A., & Caggiano, T. J. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00223-g · Cited by 5
Design of PI3K-mTOR Dual Inhibitors for Ovarian Cancer: Are we on the Right Track?
Mangala, S. S., Rathi, E., Udupa, K., Kabekkodu, S. P., Pai, K. S. R., & Kini, S. G. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673293028240326051835 · Cited by 4
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
Ambrose, M., Lee, J., Syed, A., Ahmed, Z., & Peng, G. (2025) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2025.1520734 · Cited by 4

Authors: Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T.
Affiliations: Mayo Clinic (US)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author: Abraham, Robert T.
ORCID: Abraham, Robert T.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 1995-01
Volume: 270
Issue: 2
Pages: 815-822
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.270.2.815
OpenAlex: W2158612356
Cited by: 887
References: 29
Citations by year: 2026: 10 · 2025: 20 · 2024: 28 · 2023: 37 · 2022: 38 · 2021: 37 · 2020: 39 · 2019: 31 · 2018: 25 · 2017: 38 · 2016: 25 · 2015: 31 · 2014: 26 · 2013: 31 · 2012: 29
FWCI: 9.91
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 9442 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: Mayo Foundation for Medical Education and Research
National Institutes of Health
National Institute of General Medical Sciences (R01GM047286, GM47286)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords: rapamycin, FKBP12, mTOR, TOR1, TOR2, G1/S transition, T cells, immunosuppressants, rapamycin resistance, YAC-1 cells, cDNA cloning
MeSH terms: Amino Acid Sequence, Animals, Base Sequence, Carrier Proteins, DNA-Binding Proteins, Fungal Proteins, Heat-Shock Proteins, Humans, Molecular Sequence Data, Polyenes, Protein Kinases, Tumor Cells, Cultured, Lymphoma, T-Cell, Rats, Sprague-Dawley, Sequence Homology, Amino Acid, Phosphotransferases (Alcohol Group Acceptor), DNA Primers, DNA, Complementary, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Sirolimus, Tacrolimus Binding Proteins, Saccharomyces cerevisiae Proteins, Rats, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks